Omega‐3 polyunsaturated fatty acids and its metabolite 12‐HEPE rescue busulfan disrupted spermatogenesis via target to GPR120

Abstract

AbstractBusulfan is an antineoplastic, which is always accompanied with the abnormal of spermatogonia self‐renewal and differentiation. It has been demonstrated that the omega‐3 polyunsaturated fatty acids (PUFAs) benefits mature spermatozoa. However, whether omega‐3 can protect endogenous spermatogonia and the detailed mechanisms are still unclear. Evaluate of spermatogenesis function (in vivo) were examined by histopathological analysis, immunofluorescence staining, and western blotting. The levels of lipid metabolites in testicular tissue were determined via liquid chromatography. We investigated the effect of lipid metabolites on Sertoli cells provided paracrine factors to regulate spermatogonia proliferation and differentiation using co‐culture system. In our study, we showed that omega‐3 PUFAs significantly improved the process of sperm production and elevated the quantity of both undifferentiated Lin28+ spermatogonia and differentiated c‐kit+ spermatogonia in a mouse model where spermatogenic function was disrupted by busulfan. Mass spectrometry revealed an increase in the levels of several omega‐3 metabolites in the testes of mice fed with omega‐3 PUFAs. The eicosapentaenoic acid metabolite 12‐hydroxyeicosapentaenoic acid (12‐HEPE) up‐regulated bone morphogenic protein 4 (BMP4) expression through GPR120‐ERK1/2 pathway activation in Sertoli cells and restored spermatogonia proliferation and differentiation. Our study provides evidence that omega‐3 PUFAs metabolite 12‐HEPE effectively protects spermatogonia and reveals that GPR120 might be a tractable pharmacological target for fertility in men received chemotherapy or severe spermatogenesis dysfunction.